Merck & Co (MRK) Ownership
MRK$148.04-0.72 -0.48%
Market cap$364.96BEnterprise value$415.14BRevenue (TTM)$67.30BMarket positionTop 5%
Ownership data loads after the page opens.
Merck & Co (MRK) Ownership
MRK price $148.04 -0.72 -0.48%
- Ticker
- MRK
- Price
- $148.04
- Change
- -0.72 -0.48%
- Market cap
- $364.96B
- P/E
- 149.57
- Forward P/E
- 17.66
- Dividend yield
- 2.26%
- Beta
- 0.22
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Stocklytics score
- 39
- Value
- 31
- Quality
- 61
- Growth
- 26
Stocklytics score rationale: value 31, quality 61, growth 26.
AI Score 55. Merck & Co., Inc. has a high price-to-earnings ratio of approximately 153.4, indicating overvaluation relative to earnings
Summary
Merck & Co., Inc. operates in the Healthcare sector and Drug Manufacturers - General industry. The shares offer a dividend yield of 2.3%.
Valuation
The stock trades at a P/E ratio of 151.4 and a price-to-book ratio of 8.8. These multiples indicate a demanding valuation based on the provided measures.
Quality
Net margin is 3.6%, indicating profitability, though the provided information does not include balance-sheet, cash-flow, or return metrics.
Growth
No revenue, earnings-growth, estimate-revision, or price-trend data are provided, so growth cannot be assessed from the available facts.
Risks
The elevated P/E ratio of 151.4 creates valuation risk if earnings do not support the multiple. The net margin of 3.6% also provides limited evidence of profitability strength without additional operating context.
Insights · Dividends · Forecast · Financials · Learn